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Virginia Hughes,7 Susannah Brydges,7 Sarah Hatsell,7 Chia-Jen Siao,7 Melissa G. Dominguez,7
Aris Economides,7 John D. Overton,4 Valerie Mayne,8 Peter J. Simm,2,3,8 Bryn O. Jones,2,8
Stefanie Eggers,2 Gwenaël Le Guyader,9 Fanny Pelluard,10 Tobias B. Haack,11 Marc Sturm,11
Angelika Riess,11 Stephan Waldmueller,11,12 Michael Hofbeck,12 Katharina Steindl,13 Pascal Joset,13
Anita Rauch,13 Hakon Hakonarson,5 Naomi L. Baker,2,3 and Peter G. Farlie2,3
Bone morphogenetic protein 2 (BMP2) in chromosomal region 20p12 belongs to a gene superfamily encoding TGF-b-signaling proteins
involved in bone and cartilage biology. Monoallelic deletions of 20p12 are variably associated with cleft palate, short stature, and devel-
opmental delay. Here, we report a cranioskeletal phenotype due tomonoallelic truncating and frameshift BMP2 variants and deletions in
12 individuals from eight unrelated families that share features of short stature, a recognizable craniofacial gestalt, skeletal anomalies,
and congenital heart disease.De novo occurrence and autosomal-dominant inheritance of variants, including paternal mosaicism in two
affected sisters who inherited a BMP2 splice-altering variant, were observed across all reported families. Additionally, we observed sim-
ilarity to the human phenotype of short stature and skeletal anomalies in a heterozygous Bmp2-knockout mouse model, suggesting that
haploinsufficiency of BMP2 could be the primary phenotypic determinant in individuals with predicted truncating variants and dele-
tions encompassing BMP2. These findings demonstrate the important role of BMP2 in human craniofacial, skeletal, and cardiac devel-
opment and confirm that individuals heterozygous for BMP2 truncating sequence variants or deletions display a consistent distinct
phenotype characterized by short stature and skeletal and cardiac anomalies without neurological deficits.
Bone morphogenetic proteins (BMPs), so named for their
osteogenic function,1 belong to the TGF-b superfamily of
secreted signaling proteins, which are involved in diverse
biological processes. There are over 15 BMP ligands and
two subtypes of transmembrane serine/threonine protein
kinase receptors that multimerize and phosphorylate
downstream SMAD transcription modulators to transduce
the BMP signal to the nucleus for the purpose of regulating
target genes.2 BMPs play important roles in the develop-
ment of the musculoskeletal system, most prominently
bone and cartilage. They have additional functions in
body-plan patterning3 and the development of other or-
gans, including the eyes4 and heart.5 Endochondral ossifi-
cation, the primary mechanism of bone formation in
mammals, requires mesenchymal condensation and differ-
entiation into chondrocytes to form the cartilage template
to be replaced by bone. In animal models, Bmp2 mRNA
transcripts have been detected in these pre-chondrogenic
mesenchymal condensations and hypertrophic cartilage
of long bones.6 These chondrocytes express Bmp2 and
Bmp6,7 and functional redundancy of these two molecules
in the regulation of bone formation has been demon-
strated in compound-knockout mice.8 Bmp2-null mice
show embryonic lethality with failure of amnion and
chorion formation and abnormal cardiac development,
whereas heterozygous mice have been reported to be
phenotypically normal.9
Human disorders linked to dysfunctional BMP signaling
are characterized by chondrodysplasia,10,11 skeletal and
ocular malformations,12,13 brachydactyly,14–16 abnormal
joint formation,17,18 and heterotopic ossification.19 Hu-
man BMP2 (MIM: 112261) is located in chromosomal
region 20p12,20 and variably sized monoallelic deletions
involving this locus have been reported in association
with short stature, structural and electrophysiologic car-
diac anomalies, cleft palate, distinctive facial features
(including a long philtrum), Pierre Robin sequence
(MIM: 261800), hearing impairment, and development
delay.21–24 In three previously reported individuals, BMP2
was the only deleted gene.21,22 The phenotypes of other re-
ported individuals have been complicated by the involve-
ment of multiple genes such as JAG1 (MIM: 601920)22,23 or
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other chromosomal anomalies.23 Microduplications of
non-coding DNA containing putative regulatory elements
approximately 110 kb downstream of BMP2 have been
found in individuals with brachydactyly type A2 (MIM:
112600), an autosomal-dominant phenotype character-
ized by malformations of the middle phalanx of the index
finger and abnormalities of the second toe.25,26
Herein, we report on 12 individuals from eight families
affected by de novo or inherited monoallelic BMP2
sequence variants and deletions associated with a pheno-
type characterized by short stature, palatal anomalies,
congenital heart disease or arrhythmia, and skeletal mal-
formations. Additionally, we demonstrated paternal mosa-
icism for a splice-site variant in one family with two
affected sisters born to an unaffected mosaic parent and
identified two families with a parentally inherited
interstitial 20p12 deletion involving BMP2. We propose
that the clinical overlap between individuals with BMP2
truncating sequence variants and 20p12 deletions is sug-
gestive of haploinsufficiency as the primary phenotypic
determinant.
All Australian individuals (families 1–3 and individual S1
from family 4) were identified from cohorts of children
with short stature or with syndromic non-isolated cleft pal-
ate and Pierre Robin sequence.27,28 Contact between in-
ternational collaborators was facilitated by the European
Society of Human Genetics annual meeting and the use
of GeneMatcher, a web-based tool for connecting re-
searchers with an interest in the same gene.29 Informed
written consent was obtained from all participating indi-
viduals and their parents according to local institutional
requirements and approved protocols. Clinical details of
all affected individuals were collected in PhenoTips30
with standardized Human Phenotype Ontology31 terms.
Research exome sequencing (of individuals F1-1, F1-2, S2,
S3, and S4) or chromosomal microarray (of individuals
F3-1, F3-2, F8-1, and F8-2 and probands from the other
families) were undertaken as previously described.32–35
Individuals F2-1 and S1 were sequenced by a custom-
designed Agilent SureSelect craniofacial panel comprising
79 genes and the non-coding region upstream of
SOX9 (MIM: 608160). Library preparation was performed
according to the manufacturer’s instructions. Sequencing
was performed on a Illumina MiSeq sequencer with 23
150 bp reads, and Fastq files were analyzed by Cpipe
2.1.36 Sanger sequencing was performed to validate all
sequence variants in probands and first-degree relatives.
Bone mineral density was assessed with a Horizon-W
Dual Energy X-Ray Absorptiometry (DXA) scanner (Holo-
gic). Z scores were calculated with the use of age- and
sex-specific normative data provided by Hologic, and
height matching was based on the reference dataset from
the Bone Mineral Density in Childhood Study.37
Clinical phenotypes of all affected individuals are sum-
marized in Table 1 and detailed in Table S1 and the Supple-
mental Note. Affected individuals share similar distinctive
craniofacial features such as a broad forehead with tempo-
ral narrowing, a flat midface, anteverted nares, a long phil-
trum, a thin upper lip, crowded dentition, and a cleft or
high-arched palate (Figures 1A–1H and 1A0–1H0). Skeletal
anomalies include proportionate short stature, short fifth
proximal phalanges, 11 pairs of ribs, and a wide sandal
gap (Figures 1I–1M). Phalangeal anomalies were observed
in affected individuals and most commonly involved the
fifth finger through shortening of the proximal phalanx
or clinodactyly (Table S1). Cardiac malformations were re-
ported in 4/9 (44.4%) individuals and included Ebstein
anomaly, transposition of the great arteries, ventricular
septal defects, and pulmonary valve stenosis. Cardiac ar-
rhythmias (Wolff-Parkinson-White syndrome, paroxysmal
supraventricular tachycardia, and non-specific palpita-
tions) were reported in 3/9 (33.3%) individuals. Less
common features noted in at least two individuals
were conductive hearing impairment, low-set posteriorly
rotated ears, synophrys, sternal deformity, delayed bone
age in early childhood, and L5/S1 spondylolisthesis. Three
individuals (F2-1, S1, and S4) had Pierre Robin sequence
and a cleft palate, and two of them required mandibular
distraction osteogenesis. Four individuals (F2-1, F2-2, S1,
and S3) had obstructive sleep apnea diagnosed in child-
hood or adulthood. All individuals have normal cogni-
tive development, although hypotonia in infancy was
observed in three individuals. All individuals who had pre-
viously had biochemical studies such as calcium, phos-
phate, alkaline phosphatase, or parathyroid hormone
levels showed normal results. Bone densitometry was
normal for height in all affected children. However, indi-
vidual F3-2, the father of F3-1, was found to have general-
ized osteopenia at age 54 years but no history of fracture.
The other two adults (individuals F2-2 and F8-1) have
not undergone bone densitometry studies. All BMP2
genomic lesions and their inheritance are listed in Table 2
and depicted diagrammatically in Figure 1. All sequence
variants identified are predicted to result in a truncated
protein and are absent from public population databases,
such as the ExAC Browser, gnomAD, the NHLBI Exome
Sequencing Project (ESP) Exome Variant Server, 1000 Ge-
nomes, and internal institutional databases.
Individuals F1-1 and F1-2 are affected sisters born to clin-
ically unaffected parents. Their father had a history of
Wilms tumor as a child, for which he had standard ther-
apy. He is 167.1 cm tall and has a normal palate and no
cardiac murmur. Although the pedigree of family 1 sug-
gested an autosomal-recessive mode of inheritance, we
considered nonsynonymous, splice-altering, and frame-
shift variants under either de novo dominant or recessive
inheritance models with a minor allele frequency < 1%
in population databases. Subsequent gene prioritization
was based on deleteriousness prediction and biological
and clinical relevance. Exome sequencing of individual
F1-1 yielded 567 nonsynonymous, splice-altering, and
frameshift variants that matched dominant, X-linked, or
recessive models after a standard filtering strategy. Among
these, a splice-altering variant, c.72_71delAGinsCC,
986 The American Journal of Human Genetics 101, 985–994, December 7, 2017
which deletes AG and inserts CC at the splice acceptor
site of intron 1 in the 50 UTR of BMP2 (GenBank:
NM_001200.3), was selected as a candidate causative
variant because of its association with the TGF-b signaling
pathway and bone biology. Subsequent Sanger sequencing
identified the splice acceptor variant in both affected chil-
dren, but both parents were found to be wild-type. We
exome sequenced parental DNA to identify possible mosa-
icism not detectable by Sanger sequencing; however, we
did not observe any mutant alleles in 57 reads to suggest
mosaicism in DNA from parental blood samples. Alternate
paternity was excluded through shared SNP analysis of the
father and children. After parental exome data were avail-
able, we reanalyzed the trio, and no viable recessive candi-
date variants remained. To facilitate identification of
de novo dominant or gonadal mosaic variants, we pre-
sumed that the variants responsible for the condition
would be rare and probably absent in the general pop-
ulation. Therefore, we filtered for variants not present
in the 1000 Genomes Project and not identified in con-
trol subjects by our in-house exome variant database;
this approach resulted in one additional candidate,
c.4148C>G (p.Thr1383Arg) in ABCA7 (MIM: 605414),
which encodes an ATP-binding cassette transporter pro-
tein that primarily moves lipids across membranes and
has been shown to mediate phagocytosis.38 Approxi-
mately 100 variants in ABCA7 have been reported to
be significantly associated with Alzheimer disease,38,39
and studies suggest a role in amyloid production as a
Table 1. Clinical Characteristics of Affected Individuals with




Gender 6 male, 6 female –
Growth
Gestation < 37 weeks 1/9 11.1%
Birth weight % 2.0 SD 1/9 11.1%




Weight % 2.0 SD 4/9 44.4%





Broad foreheada 8/12 66.7%









Short nosea 12/12 100.0%
Anteverted naresa 12/12 100.0%
Long philtruma 12/12 100.0%




Palatal anomalya 11/11 100.0%
Pierre Robin sequence 3/11 27.3%
Dental
Dental crowdinga 6/10 60.0%
Anterior open bitea 5/10 50.0%
Airway
Airway malacia 1/11 9.1%
Obstructive sleep apnea 4/11 36.4%
Skeletal
11 pairs of ribsa 6/9 66.7%
Sternal deformity 4/11 36.4%
L5/S1 spondylolisthesis 3/9 33.3%









Fifth-finger clinodactyly 4/11 36.4%
Single palmar crease 2/11 18.2%
Sandal gapa 8/11 72.7%
Toenail dysplasia 3/11 27.3%
Delayed bone age 2/5 40.0%
Cardiac






Normal intellecta 11/11 100.0%
Hypotonia 3/11 27.3%




aThese features were observed in 50% or more of affected individuals. Note
that denominators vary depending on the availability of data.
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contributing factor in Alzheimer disease susceptibility.40
Although residue Thr1383 is located in a highly conserved
region and was predicted to be damaging with high prob-
ability by prediction algorithms SIFT and PolyPhen-2
(0 and 0.97, respectively), we considered that the ABCA7
substitution was a less likely candidate for a cranioskeletal
phenotype. In contrast, BMP2 is strongly associated
with skeletal development, and the splice variant was ab-
sent from large population databases including the 1000
Genomes Project, COSMIC v.80, ESP6500SI, and gnomAD
and data frommore than 4,000 samples that we had previ-
ously exome sequenced in our in-house database.
To further investigate the possibility of gonosomalmosa-
icism in the ostensibly unaffected parents of individuals
F1-1 and F1-2, we extracted DNA from buccal cells and
lymphoblasts from both parents and from a paternal urine
sample. Mutant-allele-specific PCR (forward primer 50-CG
TCGGTCCTGTCCGCCC-30 and reverse primer 50-GGAA
GCTGCGCACAGTGTTG-30) identified the familial BMP2
variant in all three genomic samples from the father, con-
firming somatic mosaicism (Figure 1N, top). No PCR prod-
uct was amplified from any of the mother’s genomic
samples. To confirm mosaicism in the unaffected father
in family 1, we designed a restriction fragment length poly-
morphism (RFLP) assay given that the variant introduces a
novel EciI restriction site. Analysis of digested PCR prod-
ucts further confirmed the presence of the mutation in
the two children and their father (mosaic) and its absence
in the mother (Figure 1N, bottom).
The c.72_71delAGinsCC variant is predicted to
disrupt the BMP2 intron 1 splice acceptor, resulting in the
productionof a truncatedmRNA lackingpart of exon2 (first
coding exon). To confirm this, we performed RT-PCR anal-
ysis of lymphoblast total RNA by using primers spanning
Figure 1. Clinical Phenotype of Affected Individuals and Demonstration of Mosaicism and Splicing Alterations in Family 1
(A–F) Frontal and lateral views of the craniofacial features of individual F1-1 (A and A0), individual F1-2 (B and B0), individual F2-1
(C and C0), individual F3-1 (D and D0), individual S1 (E and E0), individual S3 (F and F0), individual S4 (G and G0), and individual F8-1
(H and H0). Note the short upturned nose, flat midface, long philtrum, micrognathia, and low-set posteriorly rotated ears, as well as
the pectus excavatum in individual S3 (F).
(I–M) Skeletal phenotypes. Note the fifth-finger clinodactyly (I), wide sandal gap (J), 11 pairs of ribs (K), L5/S1 spondylolisthesis (L), and
short fifth middle phalanx and distal phalanges (M).
(N) Mutant-allele specific PCR demonstrates mosaicism (top), such that an amplicon was detected in both affected children and their
unaffected father. Mosaicism was confirmed by RFLP (bottom). EciI digestion of amplified BMP2 resulted in two smaller fragments in
both affected children and their unaffected father (arrows).
(O) The two 20p12 deletions involving BMP2 identified in families 3 and 8 in our cohort, as well as the seven previously reported de-
letions (some of the breakpoints are approximated from individual reports21–23).
(P) RT-PCR analysis of BMP2 mRNA in family 1 (left) and the positions of all genomic sequence variants and the various splicing out-
comes (right). The BMP2 splice-site variant results in multiple mRNA products (1–5). Product 1 is the full-length BMP2 mRNA, product
3 is the BMP2 X1 alternate transcript, and product 2 is a heteroduplex of products 1 and 3. Products 4 and 5 result from apparent acti-
vation of two cryptic splice sites. Each truncated mRNA (products 3–5) is predicted to result in a 240 aa truncated BMP2.
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the c.72_71delAGinsCC variant (a forward primer in
exon 1 [50-AGAATAACTTGCGCACCCCA-30] and a reverse
primer in exon 3 [50-CCACTTCCACCACGAATCCA-30]).
The three products amplified in both parents included a
full-length BMP2 amplicon (band 1), a truncated product
missing exon 2 (band 3, BMP2, GenBank: NM_001200.3
transcript variant X1), and a heteroduplex of bands 1 and
3 (band 2). All resulting amplicons in the father and F1-1
were gel extracted and sequenced, allowing us to determine
the various splice events. The heteroduplex band was also
gel extracted and sequenced, allowing us to read the two
alleles. These three products, as well as two additional
smaller amplicons that most likely result from activation
of cryptic splice sites within exon 2, were also amplified
in both children. Sanger sequencing of gel-purified PCR
products revealed that band 4 contained 61 nucleotides of
exon 2, whereas band 5 contained only 28 nucleotides
from exon 2 (Figure 1P).
Given that all BMP2 variants identified in human indi-
viduals were predicted to be truncating and result in hap-
loinsufficiency, we re-derived and phenotyped heterozy-
gous Bmp2-knockout mice previously generated as part
of the Knockout Mouse Project.41 Bmp2þ/ mice were
generated by the VelociGene method.42,43 All experiments
were performed in accordance with the Institutional
Animal Care and Use Committee (IACUC) of Regeneron
Pharmaceuticals according to IACUC-approved protocols.
Coding exon 1 was deleted beginning just after the start
ATG to the end of coding exon 1, leaving the last 4 bp,
and was replaced with a lacZ reporter cassette containing
a neomycin resistance gene under the control of the hu-
man UBC (ubiquitin [MIM: 191340]) promoter (Figure S1).
For assessment of endogenous tissue expression, the
cassette was cloned such that the lacZ coding sequence
was in frame with the mouse Bmp2 start codon. Consistent
with previous reports, homozygous Bmp2-knockout mice
died before embryonic day 12.5 (E12.5). Expression anal-
ysis of the Bmp2-lacZ reporter in heterozygous E12.5 em-
bryos showed specific and strong staining in vibrissae fol-
licles, the facial dermis, the supraorbital dermis, Meckel’s
cartilage, and the embryonic dental epithelium that gives
rise to ameloblasts (Figures S2A–S2D), consistent with
dental anomalies and distinctive facial features in individ-
uals with BMP2 mutations. We further observed strong
expression in the cartilaginous primordia of the appendic-
ular and axial skeleton (limb and ribs; Figures S2E–S2G)
and in the developing heart (valves and ventricular-atrial
junctions; Figures S2F–S2H), consistent with the gene’s
demonstrated role and importance in skeletal and cardiac
development.
We performed computed tomography (mCT) scans of
Bmp2þ/ mice at 10 weeks to correlate with the skeletal
phenotypes observed in human individuals, mainly
abnormal numbers of rib pairs (Figures 2A–2D) and short
stature (Figures 2E–2J). Of the 13 Bmp2þ/ mice evaluated,
10 mice had 12 pairs of ribs and were missing the 13th rib
pair at thoracic vertebral 13 (T13) (Figures 2D1 and 2D2);
the remaining three mice had 12.5 pairs and were missing
one rib unilaterally (Figures 2C1 and 2C2). None of the
13 scanned wild-type littermates were found to have rib
abnormalities (Figures 2B1 and 2B2). We measured the
distance from the snout to the base of the tail (at
caudal vertebra 4), as well as femur and tibia lengths, of
Bmp2þ/ mice and their wild-type littermates (Figure S3).
We observed that the body of heterozygous Bmp2 mice
was significantly shorter than that of wild-type mice,
consistent with short stature in human individuals, but
the two groups of mice showed no differences in femur
or tibia length (Figures 2E–2G). Pixi and mCT data showed
that Bmp2þ/ mice had significantly less bone mineral
content and volume than wild-type mice (Figures 2H–2J).
Because of the significant bone mineral content and
reduced bone volume in Bmp2þ/ mice, we performed
three-point bending flexural tests to evaluate the
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normal microarray c.79G>T p.Glu27* familial; maternal






not applicable not applicable familial; paternal
4 individual S1 custom capture Agilent
SureSelect panel
normal microarray c.1_2delATinsTC p.? most likely sporadic;
not maternal
5 individual S2 exome sequencing normal microarray c.949dupC p.Tyr320Valfs*16 sporadic; de novo
6 individual S3 exome sequencing normal microarray c.987C>A p.Cys329* sporadic; de novo
7 individual S4 exome sequencing normal microarray c.460C>T p.Arg154* sporadic; de novo






not applicable not applicable familial; maternal
(de novo in proband)
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Figure 2. Computed Tomography (mCT) Scans and Quantification of Skeletal Phenotypes Observed in Bmp2þ/ andWild-Type Mice
Heterozygous Bmp2þ/ mice (n ¼ 13) and wild-type (WT) littermates (n ¼ 13) were scanned in vivo at 10 weeks for evaluation of their
skeletal phenotype.
(A) Sagittal view of a full-body scan of a WT mouse for reference.
(B1 and B2) Coronal (B1) and sagittal (B2) views of a WT mouse show a normal number of rib pairs (13). All WT mice evaluated had a
normal number of rib pairs.
(C1 and C2) Coronal (C1) and sagittal (C2) views of one of three (3/13) Bmp2þ/mice that showed 12.5 rib pairs, including the unilateral
absence or presence of a smaller floating rib (red arrow).
(D1 and D2) Coronal (D1) and sagittal (D2) views of one of ten (10/13) Bmp2þ/ mice that showed a complete absence of a rib pair at
thoracic vertebrae 13 (T13), consistent with the phenotype observed in humans.
(E–G) Femur length (E), tibia length (F), and total body length from the snout to the base of the tail (G) were measured from mCT scans of
Bmp2þ/ mice and WT littermates evaluated at 10 weeks of age (Figure S2). No significant differences were observed in femur and tibia
lengths between Bmp2þ/ and WT mice; however, heterozygous mice showed a significantly shorter body length, consistent with the
short stature in affected humans.
(H–J) Whole-body weight (H), bone mineral content (BMC) (I), and bone volume (J) were assessed through mCT and Pixi data. A trend
toward reduced body weight in the heterozygous Bmp2þ/ mice was observed, but this was not significant. Whole-body BMC and
volume were significantly lower in Bmp2þ/ mice than in WT littermates.
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mechanical properties of the femoral bones in heterozy-
gous and wild-type mice. We did not observe any signifi-
cant differences in maximum load, yield load, work to
failure, or stiffness between the two groups (data not
shown).
Although the contribution of genetics to human stature
is well established with an estimated heritability of 80%–
90%, it is generally considered a polygenic trait with
quantitatively small and variable contribution from
multiple loci. Genome-wide association studies have iden-
tified a multitude of potentially contributing loci that
all together account for about a fifth of height heritabil-
ity.44 However, ascertainment and genetic analyses of in-
dividuals and families in whom reduced stature segregates
significantly have unveiled several genes that have large
effects on human linear growth when mutated.45 Many
of these growth disorders are often accompanied by addi-
tional features, such as skeletal abnormalities and distinct
craniofacial features or other organ defects, implicating
these genes in broader human development beyond their
functions in bone formation and skeletogenesis. BMPs,
and TGF-b signaling more broadly, have been extensively
studied in vertebrate development and human disease.
Bmp2 is known to be important in skeletal, craniofacial
(including dental), and cardiac development, and tissue
expression patterns are consistent with this.6 The individ-
uals reported herein demonstrate a human phenotype
associated with monoallelic sequence variants and dele-
tions possibly resulting in BMP2 haploinsufficiency, as
well as malformations also affecting these same systems.
Although we have not experimentally demonstrated
that any of the alleles leads to nonsense-mediated decay,
all sequence variants are predicted to result in a truncated
and probably non-functional BMP2. Although the pheno-
type is recognizable, it can be mild, as demonstrated by
the variability between the affected sisters in family 1
and the normal stature in individual S1. The craniofacial
features—midface retrusion, a short upturned nose, a
long philtrum, a high-arched or cleft palate, and vari-
able degrees of micrognathia and dental crowding—are
distinctive. The observation of Pierre Robin sequence in
three individuals could shed important insights into the
pathogenesis of mandibular hypoplasia and cleft palate
in non-syndromic patients and is consistent with its
previous association with chondrogenic defects.46 BMP2
should also be considered a candidate gene in individuals
with Pierre Robin sequence and short stature. The skel-
etal phenotype involves patterning defects of the axial
skeleton (11 pairs of ribs) and brachydactyly, especially
affecting the fifth ray, such that radiographic anomalies
of the middle and distal phalanges are commonly
observed, consistent with previous observations of digital
abnormalities associated with BMP signaling dysfunc-
tion.11,14–16,25,47 Although the Bmp2-haploinsufficient
mouse was initially reported as phenotypically normal,9
we observed a similar, highly penetrant loss of the
caudal-most rib in Bmp2þ/ mice. This phenotype has
also been observed in mice homozygous for a hypomor-
phic Bmpr2 allele resulting in the posterior transformation
of the final thoracic vertebra into a lumbar vertebra and
the loss of a rib pair.5 It has been proposed that anteropos-
terior patterning of the spine could be sensitive to relative
levels of BMP and TGF-b and activin signaling.5 In addi-
tion, our detailed phenotypic analysis of the heterozygous
knockout mice identified a decrease in bone mineral
content and volume at 12 postnatal weeks and a reduc-
tion in overall body length. The short stature of affected
individuals in this cohort is consistent with the shorter
body length of Bmp2þ/ mice; however, unlike the relative
truncal shortening in mice, no skeletal disproportion was
observed in affected humans.
Assessment of bone mineral density in five children re-
vealed normal height-adjusted lumbar spine bone mineral
density (from 0.5 to 0.5 SD), and one adult demon-
strated generalized osteopenia at age 54 years but no sig-
nificant history of fracture. This is interesting also in the
context of the mouse evaluation, where no significant
differences in the mechanical properties of femurs were
observed, despite the significant differences in bone con-
tent. These results suggest that although bone composi-
tion is different in Bmp2þ/ mice, their bones are not
more prone to breakage or fracture than those of wild-
type mice. Longitudinal studies will be necessary for
determining whether a clinically significant reduction in
bone density occurs in affected adults. Although BMP2
has been applied in the orthopedic field for fracture
repair,48,49 our study opens additional potential therapeu-
tic avenues for study.
Individuals from families 3 (F3-1 and F3-2) and 8 (F8-1
and F8-2) were found to have overlapping 2.5–2.6 Mb
microdeletions involving BMP2 and surrounding genes.
Notably, previously published individuals with deletions
have had a variable spectrum of developmental delay,
generally attributed to the concomitant deletion of sur-
rounding genes. A previously reported individual with a
1.1 Mb deletion involving BMP2 alone displayed only
mild developmental delay.22 Individual F3-1 and his father
(F3-2) and individual F8-1 are intellectually normal despite
the deletion of additional genes surrounding BMP2, sug-
gesting that these genes do not play a major role in cogni-
tive development. Given that individuals with truncating
variants in BMP2 do not have any neurocognitive deficits,
it is unlikely that monoallelic loss of BMP2 is the cause of
the neurodevelopmental concerns reported in individuals
with larger 20p12 deletions. Besides the cognitive pheno-
type, the observation that individuals with BMP2 sequence
variants predicted to result in reduced amounts of BMP2
are clinically indistinguishable from those with a microde-
letion involving BMP2 suggests that the primary craniofa-
cial, skeletal, and cardiac phenotypic determinant in all
individuals reported here could be haploinsufficiency of
BMP2. Moreover, the overlap between features of the hu-
man phenotype and those of the heterozygous knockout
mouse model further supports that haploinsufficiency of
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BMP2 is themain driver of the short stature and skeletal ab-
normalities observed in human individuals.
Additional features variably observed in human individ-
uals, such as congenital heart defects, mandibular and
tooth abnormalities, and distinctive craniofacial features,
correlate well with the specific endogenous expression of
mouse Bmp2 in the corresponding tissues during murine
embryonic development, as observed by lacZ staining in
our animal model. Interestingly, the congenital heart dis-
ease observed in individuals F1-1, S1, and S2 involved
the cardiac outflow tract (transposition of the great ar-
teries, pulmonary valve stenosis, and Ebstein anomaly).
Mice with reduced Bmp2 signaling due to a hypomorphic
Bmpr2 allele also demonstrated defects of the cardiac
outflow tract,48,49 whereas conditional deletion of Bmp2
in the atrioventricular myocardium resulted in failure
to form atrioventricular cushions and abnormal myocar-
dial patterning.50 Although investigation of BMP2-related
SNPs found no association with congenital heart disease
in humans,51 data from mouse models highly suggest a
causative role for BMP2 haploinsufficiency in the cardiac
phenotypes observed in the individuals reported herein.
The diagnosis of cardiac arrhythmia in individuals S3
and S4 is in keeping with previously reported individuals
with 20p12 deletions22,23 and confirms the association.
The obstructive sleep apnea diagnosed in four individ-
uals (including F2-2, the mother of F2-1) is most likely
related to their craniofacial changes and is an important
consideration in the longitudinal medical care of other
affected individuals.
Together, our findings of individuals with BMP2 trun-
cating sequence variants and deletions associated with
craniofacial, skeletal, and cardiac phenotypes and the
related skeletal phenotypes observed in Bmp2þ/ mice
strongly support a role for BMP2 in the etiology of a
distinct cranioskeletal syndrome. On the basis of our
data, we hypothesize that haploinsufficiency is the likely
underlying mechanism, although we cannot exclude alter-
native explanations. Even though it is difficult to draw
robust genotype-phenotype correlations in a small cohort
of 12 individuals, large population datasets such as
gnomAD are relatively devoid of loss-of-function alleles
in BMP2, and further research could elucidate the func-
tional consequences of missense mutations in this gene.
These findings extend our understanding of BMP2 biology
and highlight the dosage-sensitive nature of this pathway.
BMP2 haploinsufficiency can join the growing list of rare
but highly penetrant Mendelian growth disorders, adding
to our understanding of the genes and pathways that
contribute to skeletal patterning, development, and hu-
man linear growth.
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